← Leaderboards
David Weinshenker
Emory University
$17,704,712
Attributed
$25,987,627
Total exposure
24
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,987,627 · 24
By mechanism
R01$15,049,361 · 10
RF1$6,163,921 · 3
T32$1,161,050 · 1
P30$1,122,491 · 3
P50$996,263 · 1
R56$671,961 · 1
Top collaborators
- Carlos Antonio Paladini8 shared
- Darlene A Mitrano7 shared
- Danny G Winder7 shared
- Philip V Holmes6 shared
- Tamara J Caspary5 shared
- Shella D Keilholz5 shared
- Stephen T. Warren5 shared
- Jay Michael Weiss5 shared
Most similar at Emory University
Same institution · by research overlap
- Jennifer Gladys Mulle$9,114,506
- Stephen T. Warren$38,020,626
- Gary J Bassell$24,154,007
- Sarah Shultz$6,161,841
- Tamara J Caspary$10,448,662
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBehaviorBehavioralNeuronsNorepinephrineMediatingBrainNoradrenergicS DiseaseRattusBaseAffectLocus Ceruleus StructureTransmission ProcessRodentResponseRewardsElectrophysiology (Science)In VivoBrain RegionMolecularPreventPhenotypeCell Nucleus
Grant awards (74)
Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)$575,400
T32 · FY2025 · AG
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease$505,906
R01 · FY2025 · AG · contact PI
Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)$585,650
T32 · FY2024 · AG
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement$463,811
R01 · FY2024 · DA · contact PI
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease$462,811
R01 · FY2024 · AG · contact PI
Emory Alzheimer's Disease Research Center$156,883
P30 · FY2024 · AG · contact PI
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease$88,933
RF1 · FY2024 · AG · contact PI
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement$463,811
R01 · FY2023 · DA · contact PI
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease$460,970
R01 · FY2023 · AG · contact PI
Emory Alzheimer's Disease Research Center$156,883
P30 · FY2023 · AG · contact PI
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease$1,531,573
RF1 · FY2022 · AG · contact PI
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement$463,811
R01 · FY2022 · DA · contact PI
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease$459,735
R01 · FY2022 · AG · contact PI
Emory Alzheimer's Disease Research Center$156,883
P30 · FY2022 · AG · contact PI
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement$463,741
R01 · FY2021 · DA · contact PI
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease$435,721
R01 · FY2021 · AG · contact PI
Norepinephrine-dopamine interactions underlying arousal$334,164
R01 · FY2021 · NS · contact PI
Emory Alzheimer's Disease Research Center$156,883
P30 · FY2021 · AG · contact PI
Norepinephrine-dopamine interactions underlying arousal$63,811
R01 · FY2021 · NS · contact PI
Norepinephrine-dopamine interactions underlying arousal$15,500
R01 · FY2021 · NS · contact PI
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement$471,927
R01 · FY2020 · DA · contact PI
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease$434,665
R01 · FY2020 · AG · contact PI
Norepinephrine-dopamine interactions underlying arousal$334,836
R01 · FY2020 · NS · contact PI
Emory Alzheimer's Disease Research Center$116,883
P30 · FY2020 · AG · contact PI
Mechanisms underlying selective vulnerability of locus coeruleus neurons in Alzheimer's disease$2,796,290
RF1 · FY2019 · AG · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$350,244
R01 · FY2019 · DA · contact PI
Glial huntingtin and neurodegeneration$341,250
R01 · FY2019 · NS · contact PI
Norepinephrine-dopamine interactions underlying arousal$339,711
R01 · FY2019 · NS · contact PI
Genetic and Molecular Drivers of the Schizophrenia-Associated 3q29 Deletion$671,961
R56 · FY2018 · MH
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$354,052
R01 · FY2018 · DA · contact PI
Norepinephrine-dopamine interactions underlying arousal$339,711
R01 · FY2018 · NS · contact PI
ENNCF - Rodent Behavior Core$94,519
P30 · FY2018 · NS · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$8,467
R01 · FY2018 · DA · contact PI
Norepinephrine-dopamine interactions underlying arousal$370,351
R01 · FY2017 · NS · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$351,022
R01 · FY2017 · DA · contact PI
Neurobiology of Reward Choice$195,000
R21 · FY2017 · DA · contact PI
ENNCF - Rodent Behavior Core$94,519
P30 · FY2017 · NS · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity Supplement$33,400
R01 · FY2017 · DA · contact PI
2017 Catecholamines Gordon Research Conference & Gordon Research Seminar$24,998
R13 · FY2017 · DA · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$8,467
R01 · FY2017 · DA · contact PI
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$349,530
R01 · FY2016 · DA · contact PI
Neurobiology of Reward Choice$218,880
R21 · FY2016 · DA · contact PI
ENNCF - Rodent Behavior Core$94,519
P30 · FY2016 · NS · contact PI
Characterization of the Schizophrenia-associated 3q29 Deletion in Mouse$417,252
R01 · FY2015 · GM
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition$367,393
R01 · FY2015 · DA · contact PI
ENNCF - Rodent Behavior Core$94,519
P30 · FY2015 · NS · contact PI
Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's Disease$1,747,125
RF1 · FY2014 · AG · contact PI
Characterization of the Schizophrenia-associated 3q29 Deletion in Mouse$477,402
R01 · FY2014 · GM
Effects of voluntary exercise on reinstatement of cocaine seeking$349,204
R01 · FY2014 · DA · contact PI
NOREPINEPHRINE-TrkB INTERATIONS IN ALZHEIMER'S DISEASE$190,801
P50 · FY2014 · AG · contact PI
Reinstatement of cocaine seeking by social defeat$78,000
R03 · FY2014 · DA · contact PI
Characterization of the Schizophrenia-associated 3q29 Deletion in Mouse$528,118
R01 · FY2013 · GM
Effects of voluntary exercise on reinstatement of cocaine seeking$357,122
R01 · FY2013 · DA · contact PI
NOREPINEPHRINE-TrkB INTERATIONS IN ALZHEIMER'S DISEASE$201,117
P50 · FY2013 · AG · contact PI
Reinstatement of cocaine seeking by social defeat$78,000
R03 · FY2013 · DA · contact PI
Effects of voluntary exercise on reinstatement of cocaine seeking$404,842
R01 · FY2012 · DA · contact PI
Characterization of the Schizophrenia-associated 3q29 Deletion in Mouse$404,198
R01 · FY2012 · GM
NOREPINEPHRINE-TrkB INTERATIONS IN ALZHEIMER'S DISEASE$190,802
P50 · FY2012 · AG · contact PI
Effects of voluntary exercise on reinstatement of cocaine seeking$414,611
R01 · FY2011 · DA · contact PI
NOREPINEPHRINE-TrkB INTERATIONS IN ALZHEIMER'S DISEASE$220,814
P50 · FY2011 · AG · contact PI
Effects of voluntary exercise on reinstatement of cocaine seeking$393,167
R01 · FY2010 · DA · contact PI
NOREPINEPHRINE-TrkB INTERATIONS IN ALZHEIMER'S DISEASE$192,729
P50 · FY2010 · AG · contact PI
Effects of voluntary exercise on reinstatement of cocaine seeking$20,419
R01 · FY2010 · DA · contact PI
Mechanism of Disulfiram-Induced Cocaine Abstinence$326,224
R01 · FY2009 · DA · contact PI
Mechanism of Disulfiram-Induced Cocaine Abstinence$318,912
R01 · FY2008 · DA · contact PI
Mechanism of Disulfiram-Induced Cocaine Abstinence$330,147
R01 · FY2007 · DA · contact PI
A Rodent Model of Epilepsy and Depression Co-morbidity$268,383
R01 · FY2007 · NS · contact PI
Mechanism of Disulfiram-Induced Cocaine Abstinence$344,250
R01 · FY2006 · DA · contact PI
A Rodent Model of Epilepsy and Depression Co-morbidity$319,946
R01 · FY2006 · NS · contact PI
Modeling genetically controlled DBH activity in mice$74,702
R03 · FY2006 · DA · contact PI
A Rodent Model of Epilepsy and Depression Co-morbidity$43,296
R01 · FY2006 · NS · contact PI
A Rodent Model of Epilepsy and Depression Co-morbidity$283,050
R01 · FY2005 · NS
Modeling genetically controlled DBH activity in mice$76,500
R03 · FY2005 · DA
Disulfiram, DBH, and cocaine-induced anxiety$76,500
R03 · FY2005 · DA